An FDA perspective on the nonclinical use of the X-Omics technologies and the safety of new drugs. [electronic resource]
Producer: 20090428Description: 32-5 p. digitalISSN:- 0378-4274
- Animals
- Biomarkers
- Carcinogenicity Tests
- Drug Evaluation, Preclinical
- Drug-Related Side Effects and Adverse Reactions
- Humans
- Mutagenicity Tests
- Pharmaceutical Preparations -- metabolism
- Predictive Value of Tests
- Proteomics
- Reproduction -- drug effects
- Species Specificity
- Toxicity Tests
- Toxicogenetics -- methods
- United States
- United States Food and Drug Administration
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.